You just read:

Daiichi Sankyo Terminates Development and Commercialization Agreement with Charleston Laboratories Regarding Hydrocodone Products in the U.S., including CL-108

News provided by

Daiichi Sankyo

Aug 31, 2017, 07:00 ET